Global Granulocyte Macrophage Colony Stimulating Factor Market Research Report 2024

Report ID: 1970024 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Granulocyte Macrophage Colony Stimulating Factor Market Overview
    1.1 Product Overview and Scope of Granulocyte Macrophage Colony Stimulating Factor
    1.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
        1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 CG-0070
        1.2.3 Gimsilumab
        1.2.4 GSK-3196165
        1.2.5 Lenzilumab
        1.2.6 MGN-1601
        1.2.7 Others
    1.3 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
        1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Comparison by Application: (2022-2028)
        1.3.2 Solid Tumor
        1.3.3 Lymphoma
        1.3.4 Kidney Cancer
        1.3.5 Lung Disease
        1.3.6 Others
    1.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Estimates and Forecasts
        1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2028
        1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2028
        1.4.3 Granulocyte Macrophage Colony Stimulating Factor Market Size by Region: 2017 Versus 2021 Versus 2028
2 Granulocyte Macrophage Colony Stimulating Factor Market Competition by Manufacturers
    2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Granulocyte Macrophage Colony Stimulating Factor Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Manufacturing Sites, Area Served, Product Type
    2.5 Granulocyte Macrophage Colony Stimulating Factor Market Competitive Situation and Trends
        2.5.1 Granulocyte Macrophage Colony Stimulating Factor Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Granulocyte Macrophage Colony Stimulating Factor Players Market Share by Revenue
        2.5.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Granulocyte Macrophage Colony Stimulating Factor Retrospective Market Scenario by Region
    3.1 Global Granulocyte Macrophage Colony Stimulating Factor Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Granulocyte Macrophage Colony Stimulating Factor Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Country
        3.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
        3.3.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Country
        3.4.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country
        3.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Region
        3.5.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region
        3.5.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Country
        3.6.1 Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
        3.6.2 Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Country
        3.7.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country
        3.7.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Granulocyte Macrophage Colony Stimulating Factor Historic Market Analysis by Type
    4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2017-2022)
    4.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2017-2022)
5 Global Granulocyte Macrophage Colony Stimulating Factor Historic Market Analysis by Application
    5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2017-2022)
    5.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Aduro BioTech Inc
        6.1.1 Aduro BioTech Inc Corporation Information
        6.1.2 Aduro BioTech Inc Description and Business Overview
        6.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.1.5 Aduro BioTech Inc Recent Developments/Updates
    6.2 Amgen Inc
        6.2.1 Amgen Inc Corporation Information
        6.2.2 Amgen Inc Description and Business Overview
        6.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.2.5 Amgen Inc Recent Developments/Updates
    6.3 BriaCell Therapeutics Corp
        6.3.1 BriaCell Therapeutics Corp Corporation Information
        6.3.2 BriaCell Therapeutics Corp Description and Business Overview
        6.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.3.5 BriaCell Therapeutics Corp Recent Developments/Updates
    6.4 Cold Genesys Inc
        6.4.1 Cold Genesys Inc Corporation Information
        6.4.2 Cold Genesys Inc Description and Business Overview
        6.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.4.5 Cold Genesys Inc Recent Developments/Updates
    6.5 GlaxoSmithKline Plc
        6.5.1 GlaxoSmithKline Plc Corporation Information
        6.5.2 GlaxoSmithKline Plc Description and Business Overview
        6.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
    6.6 Humanigen Inc
        6.6.1 Humanigen Inc Corporation Information
        6.6.2 Humanigen Inc Description and Business Overview
        6.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.6.5 Humanigen Inc Recent Developments/Updates
    6.7 Mologen AG
        6.6.1 Mologen AG Corporation Information
        6.6.2 Mologen AG Description and Business Overview
        6.6.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.7.5 Mologen AG Recent Developments/Updates
    6.8 Morphotek Inc
        6.8.1 Morphotek Inc Corporation Information
        6.8.2 Morphotek Inc Description and Business Overview
        6.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.8.5 Morphotek Inc Recent Developments/Updates
    6.9 Sillajen Biotherapeutics
        6.9.1 Sillajen Biotherapeutics Corporation Information
        6.9.2 Sillajen Biotherapeutics Description and Business Overview
        6.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.9.5 Sillajen Biotherapeutics Recent Developments/Updates
    6.10 Takeda Pharmaceutical Co Ltd
        6.10.1 Takeda Pharmaceutical Co Ltd Corporation Information
        6.10.2 Takeda Pharmaceutical Co Ltd Description and Business Overview
        6.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
        6.10.5 Takeda Pharmaceutical Co Ltd Recent Developments/Updates
7 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Cost Analysis
    7.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
    7.4 Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Granulocyte Macrophage Colony Stimulating Factor Distributors List
    8.3 Granulocyte Macrophage Colony Stimulating Factor Customers
9 Granulocyte Macrophage Colony Stimulating Factor Market Dynamics
    9.1 Granulocyte Macrophage Colony Stimulating Factor Industry Trends
    9.2 Granulocyte Macrophage Colony Stimulating Factor Market Drivers
    9.3 Granulocyte Macrophage Colony Stimulating Factor Market Challenges
    9.4 Granulocyte Macrophage Colony Stimulating Factor Market Restraints
10 Global Market Forecast
    10.1 Granulocyte Macrophage Colony Stimulating Factor Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Granulocyte Macrophage Colony Stimulating Factor by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Granulocyte Macrophage Colony Stimulating Factor by Type (2023-2028)
    10.2 Granulocyte Macrophage Colony Stimulating Factor Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Granulocyte Macrophage Colony Stimulating Factor by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Granulocyte Macrophage Colony Stimulating Factor by Application (2023-2028)
    10.3 Granulocyte Macrophage Colony Stimulating Factor Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Granulocyte Macrophage Colony Stimulating Factor by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Granulocyte Macrophage Colony Stimulating Factor by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Granulocyte Macrophage Colony Stimulating Factor Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Manufacturing Sites and Area Served
    Table 11. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Granulocyte Macrophage Colony Stimulating Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte Macrophage Colony Stimulating Factor as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)
    Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2017-2022)
    Table 19. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 21. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 23. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 25. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 33. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 39. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)
    Table 41. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2017-2022)
    Table 43. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)
    Table 46. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Application (2017-2022)
    Table 48. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Aduro BioTech Inc Corporation Information
    Table 50. Aduro BioTech Inc Description and Business Overview
    Table 51. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 53. Aduro BioTech Inc Recent Developments/Updates
    Table 54. Amgen Inc Corporation Information
    Table 55. Amgen Inc Description and Business Overview
    Table 56. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 58. Amgen Inc Recent Developments/Updates
    Table 59. BriaCell Therapeutics Corp Corporation Information
    Table 60. BriaCell Therapeutics Corp Description and Business Overview
    Table 61. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product
    Table 63. BriaCell Therapeutics Corp Recent Developments/Updates
    Table 64. Cold Genesys Inc Corporation Information
    Table 65. Cold Genesys Inc Description and Business Overview
    Table 66. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 68. Cold Genesys Inc Recent Developments/Updates
    Table 69. GlaxoSmithKline Plc Corporation Information
    Table 70. GlaxoSmithKline Plc Description and Business Overview
    Table 71. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 73. GlaxoSmithKline Plc Recent Developments/Updates
    Table 74. Humanigen Inc Corporation Information
    Table 75. Humanigen Inc Description and Business Overview
    Table 76. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 78. Humanigen Inc Recent Developments/Updates
    Table 79. Mologen AG Corporation Information
    Table 80. Mologen AG Description and Business Overview
    Table 81. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product
    Table 83. Mologen AG Recent Developments/Updates
    Table 84. Morphotek Inc Corporation Information
    Table 85. Morphotek Inc Description and Business Overview
    Table 86. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product
    Table 88. Morphotek Inc Recent Developments/Updates
    Table 89. Sillajen Biotherapeutics Corporation Information
    Table 90. Sillajen Biotherapeutics Description and Business Overview
    Table 91. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product
    Table 93. Sillajen Biotherapeutics Recent Developments/Updates
    Table 94. Takeda Pharmaceutical Co Ltd Corporation Information
    Table 95. Takeda Pharmaceutical Co Ltd Description and Business Overview
    Table 96. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product
    Table 98. Takeda Pharmaceutical Co Ltd Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Granulocyte Macrophage Colony Stimulating Factor Distributors List
    Table 102. Granulocyte Macrophage Colony Stimulating Factor Customers List
    Table 103. Granulocyte Macrophage Colony Stimulating Factor Market Trends
    Table 104. Granulocyte Macrophage Colony Stimulating Factor Market Drivers
    Table 105. Granulocyte Macrophage Colony Stimulating Factor Market Challenges
    Table 106. Granulocyte Macrophage Colony Stimulating Factor Market Restraints
    Table 107. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 108. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 112. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 116. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor
    Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2021 & 2028
    Figure 3. CG-0070 Product Picture
    Figure 4. Gimsilumab Product Picture
    Figure 5. GSK-3196165 Product Picture
    Figure 6. Lenzilumab Product Picture
    Figure 7. MGN-1601 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2021 & 2028
    Figure 10. Solid Tumor
    Figure 11. Lymphoma
    Figure 12. Kidney Cancer
    Figure 13. Lung Disease
    Figure 14. Others
    Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (2017-2028) & (US$ Million)
    Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Sales (2017-2028) & (K Pcs)
    Figure 18. Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2021
    Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers in 2021
    Figure 20. The Global 5 and 10 Largest Granulocyte Macrophage Colony Stimulating Factor Players: Market Share by Revenue in 2021
    Figure 21. Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)
    Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2021
    Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2017-2022)
    Figure 25. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region in 2021
    Figure 26. U.S. Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. U.K. Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Taiwan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Indonesia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Thailand Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Malaysia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Philippines Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Vietnam Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. UAE Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2017-2022)
    Figure 51. Manufacturing Cost Structure of Granulocyte Macrophage Colony Stimulating Factor
    Figure 52. Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
    Figure 53. Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
Frequently Asked Questions
Granulocyte Macrophage Colony Stimulating Factor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Granulocyte Macrophage Colony Stimulating Factor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Granulocyte Macrophage Colony Stimulating Factor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Glucosylceramidase

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More